• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic drug monitoring following crushed administration of delayed-release posaconazole tablets via enteral feeding tubes.

作者信息

Stevens Ryan W, O'Connell Casey, Huang Angie, Epps Kevin L, Ilges Dan

机构信息

Department of Pharmacy Services, Mayo Clinic, 200 1st St. SW, Rochester 55902, MN, USA.

Department of Pharmacy Services, Mayo Clinic, Scottsdale, AZ, USA.

出版信息

J Antimicrob Chemother. 2023 Feb 1;78(2):553-555. doi: 10.1093/jac/dkac427.

DOI:10.1093/jac/dkac427
PMID:36544355
Abstract
摘要

相似文献

1
Therapeutic drug monitoring following crushed administration of delayed-release posaconazole tablets via enteral feeding tubes.通过肠内喂养管碾碎服用缓释泊沙康唑片后的治疗药物监测。
J Antimicrob Chemother. 2023 Feb 1;78(2):553-555. doi: 10.1093/jac/dkac427.
2
Enteral feeding tube administration with therapeutic drug monitoring of crushed posaconazole tablets and opened isavuconazonium sulfate capsules.通过肠内饲管给药并对碾碎的泊沙康唑片和打开的硫酸艾沙康唑胶囊进行治疗药物监测。
J Antimicrob Chemother. 2022 Apr 27;77(5):1417-1423. doi: 10.1093/jac/dkac035.
3
Successful enteral administration of crushed posaconazole delayed-release tablets in children.成功经口给予压碎的泊沙康唑延迟释放片在儿童中的应用。
Pediatr Blood Cancer. 2024 Feb;71(2):e30782. doi: 10.1002/pbc.30782. Epub 2023 Nov 21.
4
The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.健康受试者中鼻胃管给药与口服片剂形式的曲伐沙星的生物利用度。
Am J Surg. 1998 Dec;176(6A Suppl):23S-26S. doi: 10.1016/s0002-9610(98)00216-5.
5
A systematic approach for assessing the suitability of enteral feeding tubes for the administration of controlled-release pellet formulations.一种系统的方法，用于评估肠内喂养管用于控释微丸制剂给药的适用性。
Int J Pharm. 2022 Jan 25;612:121286. doi: 10.1016/j.ijpharm.2021.121286. Epub 2021 Nov 11.
6
Nasogastric administration of garenoxacin as crushed tablets with and without concomitant enteral feeding in healthy subjects.在健康受试者中，将加替沙星制成的压片通过鼻胃管给药，同时有或没有给予肠内营养。
Drugs R D. 2007;8(1):43-50. doi: 10.2165/00126839-200708010-00004.
7
Serum Levels of Crushed Posaconazole Delayed-Release Tablets.泊沙康唑缓释片碾碎后的血清水平。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02688-18. Print 2019 May.
8
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.治疗药物监测和慢性肺曲霉病患者使用延迟释放泊沙康唑片的不良事件。
J Antimicrob Chemother. 2019 Apr 1;74(4):1056-1061. doi: 10.1093/jac/dky539.
9
Single-centre study of therapeutic drug monitoring of posaconazole in lung transplant recipients: factors affecting trough plasma concentrations.单中心研究：肺移植受者中泊沙康唑的治疗药物监测：影响谷浓度的因素。
J Antimicrob Chemother. 2018 Mar 1;73(3):748-756. doi: 10.1093/jac/dkx440.
10
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding.经鼻胃管给予和不给予肠内喂养时泰比培南压碎制剂的相对生物利用度。
J Antimicrob Chemother. 2022 Dec 23;78(1):205-208. doi: 10.1093/jac/dkac375.

引用本文的文献

1
The Pitfalls and Opportunities With Posaconazole DR Oral Suspension.泊沙康唑缓释口服混悬液的陷阱与机遇
J Pediatr Pharmacol Ther. 2025 Jun;30(3):410-413. doi: 10.5863/JPPT-24-00018. Epub 2025 Jun 9.
2
Assessment of the Effective Dose of Isavuconazole, Itraconazole, Posaconazole, and Voriconazole to Achieve Goal Serum Concentrations in Pediatric Patients at a Single Center.单中心评估伊沙康唑、伊曲康唑、泊沙康唑和伏立康唑在儿科患者中达到目标血清浓度的有效剂量
J Pediatr Pharmacol Ther. 2025 Feb;30(1):112-122. doi: 10.5863/1551-6776-30.1.112. Epub 2025 Feb 10.
3
Zoonotic feline sporotrichosis: a small case cluster in Perth, Western Australia, and a review of previous feline cases from Australia.
猫源性芽生菌病：西澳大利亚州珀斯的一个小病例群集，以及对来自澳大利亚的以前猫源性病例的回顾。
Aust Vet J. 2024 Dec;102(12):638-645. doi: 10.1111/avj.13375. Epub 2024 Oct 20.
4
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023.2012年至2023年间美国食品药品监督管理局批准的无定形固体分散体药物产品的趋势。
Int J Pharm X. 2024 Jun 3;7:100259. doi: 10.1016/j.ijpx.2024.100259. eCollection 2024 Jun.